207 related articles for article (PubMed ID: 8554221)
1. Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus.
Henry RR
Ann Intern Med; 1996 Jan; 124(1 Pt 2):97-103. PubMed ID: 8554221
[TBL] [Abstract][Full Text] [Related]
2. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
Turner R; Cull C; Holman R
Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206
[TBL] [Abstract][Full Text] [Related]
3. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
4. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
5. Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus.
Henry RR; Genuth S
Ann Intern Med; 1996 Jan; 124(1 Pt 2):175-7. PubMed ID: 8554214
[TBL] [Abstract][Full Text] [Related]
6. Insulin therapy in type 2 diabetes.
Mudaliar S; Edelman SV
Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
[TBL] [Abstract][Full Text] [Related]
7. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
8. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
9. Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats.
Anwer T; Sharma M; Pillai KK; Iqbal M
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):498-503. PubMed ID: 18346053
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control in diabetes mellitus: have changes in therapy made a difference?
Nathan DM; McKitrick C; Larkin M; Schaffran R; Singer DE
Am J Med; 1996 Feb; 100(2):157-63. PubMed ID: 8629649
[TBL] [Abstract][Full Text] [Related]
11. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.
Colwell JA
Ann Intern Med; 1996 Jan; 124(1 Pt 2):131-5. PubMed ID: 8554205
[TBL] [Abstract][Full Text] [Related]
12. Importance of glucose control.
Edelman SV
Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
[TBL] [Abstract][Full Text] [Related]
13. Re-examining insulin compared to non-insulin therapies for type 2 diabetes: when in the disease trajectory is insulin preferable?
Mishriky BM; Cummings DM; Tanenberg R; Pories WJ
Postgrad Med; 2018 Nov; 130(8):653-659. PubMed ID: 30301398
[TBL] [Abstract][Full Text] [Related]
14. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
Chan JL; Abrahamson MJ
Mayo Clin Proc; 2003 Apr; 78(4):459-67. PubMed ID: 12683698
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.
Yki-Järvinen H; Ryysy L; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Salo S; Seppälä P; Tulokas T; Viikari J; Taskinen MR
J Clin Endocrinol Metab; 1997 Dec; 82(12):4037-43. PubMed ID: 9398709
[TBL] [Abstract][Full Text] [Related]
17. Non-insulin-dependent diabetes mellitus: a clinical strategy.
Skyler JS
Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
[TBL] [Abstract][Full Text] [Related]
18. Facts about combination therapy in NIDDM: insulin + oral antidiabetic agents.
de Leeuw IH; Dorny N
Diabetes Res Clin Pract; 1988; 4 Suppl 1():71-4. PubMed ID: 3042338
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different insulin regimens in elderly patients with NIDDM.
Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
[TBL] [Abstract][Full Text] [Related]
20. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
